IBS Price Prediction IBS

As of 18 October 2026, IBS (IBS) is trading at $7.4703.

24h move: +0.00%  |  Market cap: $9.80M  |  24h volume: $1.09M

Data is sourced from the CoinMarketCap API. Not investment advice.

IBS (IBS) is trading at $7.4703 as of 18 October 2026. With a market cap of $9.80M, IBS currently sits in the micro-cap segment of the crypto market. The coin moved +0.00% over the last 24 hours. Reported 24-hour volume is $1.09M.

IBS is posting a modest gain, which is common during the early price-discovery phase of a fresh listing. A larger breakout would usually require stronger volume or a clear catalyst from the project or the broader market.

• The coin is up +0.00% in the last 24 hours, which may reflect early buyer interest, speculative momentum, or improving sentiment across the broader crypto market.
• The volume-to-market-cap ratio is 11.10%, a useful signal for judging whether liquidity is strong enough to support sustainable moves.
• Bitcoin direction and overall risk appetite still shape how aggressively traders treat smaller altcoins like IBS.
• Exchange listings, roadmap updates, and token-related news can quickly change the narrative for a fresh listing.

IBS is attracting some early interest, but newly listed coins remain high-risk assets. Traders should review the team, token utility, roadmap, and liquidity profile before treating early momentum as a durable trend.

Micro-cap assets can behave very differently depending on liquidity and market mood.

Short Term (1-4 Weeks)

In the short term, the main drivers are market sentiment, liquidity, and whether the first wave of buying interest holds up. Current momentum is positive, but it still needs consistent volume.

Medium Term (1-3 Months)

Over the next one to three months, adoption signals such as exchange support, community growth, and ecosystem activity will matter more than the initial listing spike. The current market cap stands at $9.80M.

Long Term (6-12 Months+)

Longer term, IBS will need sustainable product demand, ongoing development, and a credible roadmap to justify lasting upside. It first appeared in our listings on 09.05.2026.

IBS is a newly listed micro-cap asset, which places it in the highest-risk category. Only investors who fully understand the risks of fresh listings — including rug pulls, low liquidity, and extreme volatility — should consider a position, and only with capital they can afford to lose entirely.